Page last updated: 2024-10-25

cilostazol and Impaired Glucose Tolerance

cilostazol has been researched along with Impaired Glucose Tolerance in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Body weight and abdominal fat was increased in OLETF rats but cilostazol supplementation did not alter them."7.70Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM. ( Harada, N; Minami, A; Nakamura, T; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 1999)
"Body weight and abdominal fat was increased in OLETF rats but cilostazol supplementation did not alter them."3.70Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM. ( Harada, N; Minami, A; Nakamura, T; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wada, T1
Onogi, Y1
Kimura, Y1
Nakano, T1
Fusanobori, H1
Ishii, Y1
Sasahara, M1
Tsuneki, H1
Sasaoka, T1
Nakaya, Y1
Minami, A1
Sakamoto, S1
Niwa, Y1
Ohnaka, M1
Harada, N1
Nakamura, T1

Other Studies

2 other studies available for cilostazol and Impaired Glucose Tolerance

ArticleYear
Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions.
    European journal of pharmacology, 2013, May-05, Volume: 707, Issue:1-3

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Chronic Disease; Cilostazol; Diabetes Mellitus, E

2013
Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM.
    Diabetes, obesity & metabolism, 1999, Volume: 1, Issue:1

    Topics: Abdomen; Adipose Tissue; Animals; Blood Glucose; Body Weight; Cilostazol; Diabetes Mellitus, Type 2;

1999